aCella - Tox - an assay designed to measure cell cytoxicity

16 Citations

A bioluminescence, non-radioactive cytotoxicity assay designed to quantitatively measure the release of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) from mammalian cell lines or bacterial cells.

5000 Ramos cells/well were incubated with serially diluted Rituxan antibody for 15 minutes prior to the addition of purified NK cells stimulated overnight with IL-2. The ADCC reaction was further incubated for 2 hours at the specified E:T ratios. % Cytotoxicity was measured using the aCellaTOX assay.
5000 Ramos cells/well were incubated with serially diluted Rituxan antibody for 15 minutes prior to the addition of purified NK cells stimulated overnight with IL-2 . The ADCC reaction was further incubated for 3.5 hours at the specified E:T ratios. % Cytotoxicity was measured using the aCellaTOX assay. 3.5hour timepoint has been optimized with the 10:1 E:T ratio.
The graph shows an antibody titration of Rituximab from0.000977 to 1ug/ml incubated with 5% baby rabbit complement and 5000 Daudi target cells for 30 minutes at 37oC
5000 Daudi cells/well were incubated with serially diluted Rituxan antibody for 15 minutes prior to the addition of purified NK cells stimulated overnight with IL-2. The ADCC reaction was further incubated for 2 hours at the specified E:T ratios. % ADCC was measured using the aCella-TOX assay.Log (EC50) value for E:T 25:1 was -2.344 and for E:T 10:1 was -2.213
A Direct comparison of 51Cr and aCella-TOX was carried out with the same donors with Daudi Cells. Log (EC50) value for aCella-TOX was -2.23, and that for 51Cr was -2.087 for Donor A.
A Direct comparison of 51Cr and aCella-TOX was carried out with the same donors with Daudi Cells. Log(EC50) value for aCella-TOX was -2.612, and that for51Cr was -2.77 for Donor B.
5000 Ramos cells/well were incubated with serially diluted Rituxan antibody for 15 minutes prior to the addition of purified NK cells stimulated overnight with IL-2. The ADCC reaction was further incubated for 2 hours at the specified E:T ratios. % Cytotoxicity was measured using the aCellaTOX assay.
Roll over image to zoom in Click on image to zoom
5000 Ramos cells/well were incubated with serially diluted Rituxan antibody for 15 minutes prior to the addition of purified NK cells stimulated overnight with IL-2. The ADCC reaction was further incubated for 2 hours at the specified E:T ratios. % Cytotoxicity was measured using the aCellaTOX assay.
5000 Ramos cells/well were incubated with serially diluted Rituxan antibody for 15 minutes prior to the addition of purified NK cells stimulated overnight with IL-2 . The ADCC reaction was further incubated for 3.5 hours at the specified E:T ratios. % Cytotoxicity was measured using the aCellaTOX assay. 3.5hour timepoint has been optimized with the 10:1 E:T ratio.
The graph shows an antibody titration of Rituximab from0.000977 to 1ug/ml incubated with 5% baby rabbit complement and 5000 Daudi target cells for 30 minutes at 37oC
5000 Daudi cells/well were incubated with serially diluted Rituxan antibody for 15 minutes prior to the addition of purified NK cells stimulated overnight with IL-2. The ADCC reaction was further incubated for 2 hours at the specified E:T ratios. % ADCC was measured using the aCella-TOX assay.Log (EC50) value for E:T 25:1 was -2.344 and for E:T 10:1 was -2.213
A Direct comparison of 51Cr and aCella-TOX was carried out with the same donors with Daudi Cells. Log (EC50) value for aCella-TOX was -2.23, and that for 51Cr was -2.087 for Donor A.
A Direct comparison of 51Cr and aCella-TOX was carried out with the same donors with Daudi Cells. Log(EC50) value for aCella-TOX was -2.612, and that for51Cr was -2.77 for Donor B.

Go to Full Product Details

Data Sheet
Protocol
Safety Data Sheet

SKU: CLATOX100-4

Size: 1000 Tests
Price:
$1,755.00
Ships: 1-2 business days
GAPDH is an important enzyme in the glycolysis and gluconeogenesis pathways. This homotetrameric enzyme catalyzes the oxidative phosphorylation of D-glyceraldehyde-3-phosphate to 1,3-diphosphoglycerate in the presence of cofactor and inorganic phosphate. In the aCella-TOX reaction scheme the release of GAPDH is coupled to the activity of the enzyme 3-Phosphoglyceric Phosphokinase (PGK) to produce ATP. ATP is detected via the luciferase, luciferin Bioluminescence methodology. Further, aCella-TOX is a homogeneous cytotoxicity assay; alternatively in dual mode, aCella-TOX can measure cytotoxicity and cell viability in the same plate. Culture supernatants can also be removed from the original plate and assayed in a different plate, allowing kinetics runs to be set up. The assay is non-destructive, allowing the monitoring of additional parameters such as gene expression.
Luminometer
For research use only. Not for use in diagnostic procedures.
United States
Store contents as labeled
Ships overnight (domestic), International Priority Shipping
CLATOX100-3P: 500 Tests (with 5 Lumi Plates + 5 TC Plates)
  • 1. 4X Enzyme Assay Reagent Part# 6001 x 1 (Storage: -20°C)
  • 2. Enzyme Assay Diluent Part# 3008 x 1 (Storage: 2-8°C)
  • 3. 50X Detection Reagent Part# 6002 x 1 (Storage: -20°C)
  • 4. 5.5X Detection Assay Diluent Part# 3009 x 1 (Storage: -20°C)
  • 5. Glyeraldehyde 3-Phosphate-G3P Part# 6003 x 1 (Storage: -20°C)
  • 6. Lysis Buffer Part# 3035 x 1 (Storage: 2-8°C)
  • 7. 5 Luminescence Plates + 5 Tissue Culture Plates (Catalog# CLATOX100-3P)

    • CLATOX100-3: 500 Tests
  • 1. 4X Enzyme Assay Reagent Part# 6001 x 1 (Storage: -20°C)
  • 2. Enzyme Assay Diluent Part# 3008 x 1 (Storage: 2-8°C)
  • 3. 50X Detection Reagent Part# 6002 x 1 (Storage: -20°C)
  • 4. 5.5X Detection Assay Diluent Part# 3009 x 1 (Storage: -20°C)
  • 5. Glyeraldehyde 3-Phosphate-G3P Part# 6003 x 1 (Storage: -20°C)
  • 6. Lysis Buffer Part# 3035 x 1 (Storage: 2-8°C)

    • CLATOX100-4: 1000 Tests
  • 1. 4X Enzyme Assay Reagent Part# 6001 x 2 (Storage: -20°C)
  • 2. Enzyme Assay Diluent Part# 3008 x 2 (Storage: 2-8°C)
  • 3. 50X Detection Reagent Part# 6002 x 2 (Storage: -20°C)
  • 4. 5.5X Detection Assay Diluent Part# 3009 x 2 (Storage: -20°C)
  • 5. Glyeraldehyde 3-Phosphate-G3P Part# 6003 x 2 (Storage: -20°C)
  • 6. Lysis Buffer Part# 3035 x 2 (Storage: 2-8°C)

    • CLATOX100-3L: 500 Tests (with 5 Lumi Plates)
  • 1. 4X Enzyme Assay Reagent Part# 6001 x 1 (Storage: -20°C)
  • 2. Enzyme Assay Diluent Part# 3008 x 1 (Storage: 2-8°C)
  • 3. 50X Detection Reagent Part# 6002 x 1 (Storage: -20°C)
  • 4. 5.5X Detection Assay Diluent Part# 3009 x 1 (Storage: -20°C)
  • 5. Glyeraldehyde 3-Phosphate-G3P Part# 6003 x 1 (Storage: -20°C)
  • 6. Lysis Buffer Part# 3035 x 1 (Storage: 2-8°C)
  • 7. 5 Luminescence Plates (Catalog# CLATOX100-3L)

    • Product Specific References

    PMID Publication
    26350593Overholser, J., et al. 2015. Anti-tumor effects of peptide therapeutic and peptide vaccine antibody co-targeting HER-1 and HER-2 in esophageal cancer (EC) and HER-1 and IGF-1R in triple …. Vaccines (Basel), 519-43.
    30867324Sano, R., et al. 2019. An antibody-drug conjugate directed to the ALK receptor demonstrates efficacy in preclinical models of neuroblastoma. Science Translational Medicine, eaau9732.
    31070879Riss, T., et al. 2019. Cytotoxicity assays: in vitro methods to measure dead cells. Assay Guidance Manual [Internet]. Bethesda (MD): Eli Lilly & Company and the National Center for Advancing Translational Sciences, .
    25391374Sanabria-Figueroa, E., et al. 2015. Insulin-like growth factor-1 receptor signaling increases the invasive potential of human epidermal growth factor receptor 2-overexpressing breast cancer cells via Src-focal adhesion kinase and forkhead box protein M1. Molecular Pharmacology , 150-61.
    25915748Simhadri, V.R., et al. 2015. A Human Anti-M2 Antibody Mediates Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC) and Cytokine Secretion by Resting and Cytokine-Preactivated Natural Killer (NK) Cells. PLoS One, e0124677.
    30804020Bekaii-Saab, T.., et al. 2019. Phase I Immunotherapy Trial with Two Chimeric HER-2 B-Cell Peptide Vaccines Emulsified in Montanide ISA 720VG and Nor-MDP Adjuvant in Patients with Advanced Solid Tumors. Clinical Trial Clin Cancer Res, 3495-3507.
    25932028Tsuji, W., et al. 2015. Effects of immunosuppressive drugs on viability and susceptibility of adipose-and bone marrow-derived mesenchymal stem cells. Frontiers in Immunology, 131.
    26431358Fisher, T.L., et al. 2016. Generation and preclinical characterization of an antibody specific for SEMA4D. Mabs, 150-62.
    26390038Liu, J., et al. 2015. Pre-clinical development of a humanized anti-CD47 antibody with anti-cancer therapeutic potential. PLoS One, e0137345.
    34395257Lewis, C.S., et al. 2021. A First-In-Class, Humanized Antibody Targeting Alternatively Spliced Tissue Factor: Preclinical Evaluation in an Orthotopic Model of Pancreatic Ductal Adenocarcinoma. Frontiers in Oncology, 691685.
    36211807Guo, L., et al. 2022. A newly discovered PD-L1 B-cell epitope peptide vaccine (PDL1-Vaxx) exhibits potent immune responses and effective anti-tumor immunity in multiple syngeneic mice models and (synergizes) in combination with a dual HER-2 B-cell vaccine (B-Vaxx). Oncoimmunology, 2127691.
    25542973Zhukovskaya, N.L., et al. 2015. The processivity factor complex of feline herpes virus-1 is a new drug target. Antiviral Research, 17-20.
    32307580Zecca, A., et al. 2020. Energy metabolism and cell motility defect in NK-cells from patients with hepatocellular carcinoma. Cancer Immunology, Immunotherapy, 1589-1603.
    34895654Láng, J.A., et al. 2020. In vitro functional characterization of biosimilar therapeutic antibodies. Drug Discovery Today: Technologies, 41-50.
    28970093Hoffman, F., et al. 2018. A mathematical model of antibody-dependent cellular cytotoxicity (ADCC). Journal of Theoretical Biology, 39-50.
    34931298Dash, R., et al. 2022. Assessment of Functional Characterization and Comparability of Biotherapeutics: a Review. AAPS Journal, 15.

    Bulk Order aCella - Tox - an assay designed to measure cell cytoxicity

    Related Products

    Recently Viewed